Trust P M, Rosei E A, Brown J J, Fraser R, Lever A F, Morton J J, Robertson J I
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):799-803.
1 The actions of labetalol 1.0-2.0 mg/kg intravenously on blood pressure, heart rate, plasma angiotensin II and aldosterone concentrations have been studied in 20 recumbent hypertensive patients. 2 In all subjects there was a reduction in systolic and diastolic blood pressures within 5 min of completion of injection. 3 Severe hypotension was not seen but three patients who had a marked fall in blood pressure experienced side-effects. Postural hypotension was common at the end of the study. 4 Labetalol caused significant reduction in heart rate. 5 Labetalol induced significant lowering of plasma angiotensin II and in plasma aldosterone concentrations, which were most obvious when these were increased initially; overall there was a close correlation between concurrent measurements of angiotensin II and aldosterone concentrations. 6 In five patients a comparison was made against propranolol 10 mg intravenously. Labetalol was more effective in lowering blood pressure but less effective in reducing pulse rate of plasma angiotensin II concentration.
对20例卧位高血压患者研究了静脉注射1.0 - 2.0mg/kg拉贝洛尔对血压、心率、血浆血管紧张素II和醛固酮浓度的影响。
在所有受试者中,注射完成后5分钟内收缩压和舒张压均下降。
未观察到严重低血压,但有3例血压明显下降的患者出现了副作用。研究结束时体位性低血压很常见。
拉贝洛尔使心率显著降低。
拉贝洛尔使血浆血管紧张素II和血浆醛固酮浓度显著降低,当这些浓度最初升高时最为明显;总体而言,血管紧张素II和醛固酮浓度的同步测量之间存在密切相关性。
对5例患者静脉注射10mg普萘洛尔进行了比较。拉贝洛尔在降低血压方面更有效,但在降低血浆血管紧张素II浓度的脉率方面效果较差。